MARKET

OPK

OPK

Opko Health
NASDAQ
1.270
-0.010
-0.78%
After Hours: 1.250 -0.02 -1.57% 18:31 05/22 EDT
OPEN
1.270
PREV CLOSE
1.280
HIGH
1.300
LOW
1.240
VOLUME
3.16M
TURNOVER
--
52 WEEK HIGH
1.600
52 WEEK LOW
0.9769
MARKET CAP
958.97M
P/E (TTM)
-4.6384
1D
5D
1M
3M
1Y
5Y
1D
Here's Why You Should Retain OPK Stock in Your Portfolio for Now
NASDAQ · 2d ago
Weekly Report: what happened at OPK last week (0511-0515)?
Weekly Report · 5d ago
ModeX Therapeutics to present preclinical in vivo CAR-T generation data at ASGCT 2026
PUBT · 05/12 12:00
Spotlight On Promising Penny Stocks For May 2026
Simply Wall St · 05/11 17:05
Weekly Report: what happened at OPK last week (0504-0508)?
Weekly Report · 05/11 10:32
Weekly Report: what happened at OPK last week (0427-0501)?
Weekly Report · 05/04 10:29
NeoGenomics, Spotify, Opko, Appian, Meta Trending With Analysts
TipRanks · 05/02 09:01
Opko Health announces annual shareholder meeting
PUBT · 04/30 20:08
More
About OPK
OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company’s segments include pharmaceutical and diagnostics. The pharmaceutical segment consists of the pharmaceutical operations it operates in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its global pharmaceutical research and development operations. The diagnostics segment primarily consists of clinical laboratory operations through BioReference and its point-of-care operations. Its pharmaceutical business features Somatrogon (hGH-CTP), a once-weekly human growth hormone injection, and it is marketed under the brand name NGENLA. The Company, through its pharmaceutical division, manufactures and sells Rayaldee, a United States Food and Drug Administration (FDA) approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.

Webull offers OPKO Health Inc stock information, including NASDAQ: OPK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OPK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OPK stock methods without spending real money on the virtual paper trading platform.